TY - JOUR
T1 - A multichannel microchip containing 16 chambers packed with antibody-functionalized beads for immunofluorescence assay
AU - Peng, Si
AU - Hong, Tingting
AU - Liang, Wenbin
AU - Liu, Wenfang
AU - Chen, Chuanpin
N1 - Publisher Copyright:
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2019/3/7
Y1 - 2019/3/7
N2 - A multichannel chip containing 16 microchambers was developed for fast and sensitive immunoassays. In each chamber, antibody-functionalized nonmagnetic beads were applied as the solid phase to capture target antigens. Four types of IgGs (human, rabbit, chicken, and mouse) could be detected simultaneously by our combining this microchip with a sandwich immunoassay technique. A three-layer chip structure was investigated for integration of multiple processes, including washing, immune reaction, and detection, in one microchip. Moreover, the proposed chip design could improve batch-to-batch repeatability and avoid interferences between different channels without the preparation of complex microvalves. The total operation time of this system was less than 30 min, with a desirable detection limit of 0.2 pg/mL. The results indicate that the microfluidic platform is promising for the immunoassay of multiple clinical biomarkers.
AB - A multichannel chip containing 16 microchambers was developed for fast and sensitive immunoassays. In each chamber, antibody-functionalized nonmagnetic beads were applied as the solid phase to capture target antigens. Four types of IgGs (human, rabbit, chicken, and mouse) could be detected simultaneously by our combining this microchip with a sandwich immunoassay technique. A three-layer chip structure was investigated for integration of multiple processes, including washing, immune reaction, and detection, in one microchip. Moreover, the proposed chip design could improve batch-to-batch repeatability and avoid interferences between different channels without the preparation of complex microvalves. The total operation time of this system was less than 30 min, with a desirable detection limit of 0.2 pg/mL. The results indicate that the microfluidic platform is promising for the immunoassay of multiple clinical biomarkers.
KW - Antibody
KW - Immunoassay
KW - Microchip
KW - Point-of-care testing
UR - http://www.scopus.com/inward/record.url?scp=85060891845&partnerID=8YFLogxK
U2 - 10.1007/s00216-019-01601-y
DO - 10.1007/s00216-019-01601-y
M3 - Article
C2 - 30706077
AN - SCOPUS:85060891845
SN - 1618-2642
VL - 411
SP - 1579
EP - 1589
JO - Analytical and Bioanalytical Chemistry
JF - Analytical and Bioanalytical Chemistry
IS - 8
ER -